ENHANCEMENT OF INTRACELLULAR GROWTH OF MYCOBACTERIUM-TUBERCULOSIS IN HUMAN MONOCYTES BY TRANSFORMING GROWTH-FACTOR-BETA-1

被引：160

作者：

HIRSCH, CS ^{[1
]}

YONEDA, T ^{[1
]}

AVERILL, L ^{[1
]}

ELLNER, JJ ^{[1
]}

TOOSSI, Z ^{[1
]}

机构：

[1] VET ADM MED CTR,CLEVELAND,OH

来源：

JOURNAL OF INFECTIOUS DISEASES | 1994年 / 170卷 / 05期

关键词：

D O I：

10.1093/infdis/170.5.1229

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The production of transforming growth factor-beta (TGF beta 1) by human monocytes (MN) infected with Mycobacterium tuberculosis and its effects on the intracellular fate of the organism were studied. M. tuberculosis infection of MN induced both expression of mRNA and secretion of tumor necrosis factor-alpha (TNF alpha) and TGF beta 1 protein. Neutralizing antibody to TGF beta 1 reduced the intracellular growth of M. tuberculosis. The growth-enhancing effects of TGF beta 1 could not be explained by increased initial bacterial load. Preculture with TGF beta 1 decreased uptake of M. tuberculosis. Exposure of MN to increasing concentrations of TGF beta 1 before or after infection with M. tuberculosis accelerated intracellular bacterial replication. Both TNF alpha and interferon-gamma (IFN-gamma) limited mycobacterial replication. TGF beta 1 (10 ng/mL) abrogated the bacteriostatic effects of TNF alpha and IFN-gamma. Within the infected focus, TGF beta 1 produced by mononuclear phagocytes may play an important role in the pathogenesis of tuberculosis, in part by modulating the response to potentially protective cytokines such as TNF alpha and IFN-gamma.

引用

页码：1229 / 1237

页数：9

共 42 条

[1] EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES
ASSOIAN, RK
FLEURDELYS, BE
STEVENSON, HC
MILLER, PJ
MADTES, DK
RAINES, EW
ROSS, R
SPORN, MB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6020 - 6024
[2] TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
BARNES, PF
BLOCH, AB
DAVIDSON, PT
SNIDER, DE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) : 1644 - 1650
[3] BERMUDEZ LE, 1993, J IMMUNOL, V150, P1838
[4] BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[5] Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9
[6] RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS
BRUDNEY, K
DOBKIN, J
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04): : 745 - 749
[7] KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES
CHAN, J
XING, Y
MAGLIOZZO, RS
BLOOM, BR
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1111 - 1122
[8] DRUG-RESISTANT TUBERCULOSIS IN AN URBAN-POPULATION INCLUDING PATIENTS AT RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
CHAWLA, PK
KLAPPER, PJ
KAMHOLZ, SL
POLLACK, AH
HEURICH, AE
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02): : 280 - 284
[9] CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217
[10] DENIS M, 1991, CLIN EXP IMMUNOL, V84, P200, DOI 10.1111/j.1365-2249.1991.tb08149.x

← 1 2 3 4 5 →